Stocks and Sectors

Biotechnology M&As, Wholesale Mix the Markets and ETFs

Tom Lydon (ETF Trends) submits:
Mergers and acquisitions are starting to be a sign of the times. An unexpected decline in wholesale inventories wasn’t enough to put the markets in the red in early trading, thanks to a slew of M&A deals in the biotechnology and financial sectors.
Abbott Laboratories (ABT) is going to buy [...]

How to Reduce Foreign Oil Imports

Michael Fitzsimmons submits:
The United States uses ~25% of the world’s oil and imports ~65% of it. The economic, environmental, and national security issues arising from this dependence on foreign oil are obvious. The chart below summarizes American wealth transferred overseas to purchase the oil it must have.

Year

Barrels of Oil Imported

Money Sent Overseas

2008

$475,000,000,000

2009

4,350,000,000 barrels

$265,000,000,000

2010 (January [...]

Fairfax Financial: Don’t Forget the Good Side of the CDS Market

Streetwise Blog submits:

By Tara Perkins
Fairfax Financial (FRFHF.PK) has its fingers crossed that U.S. President Barack Obama won’t bow to pressure to curb trading of credit default swaps.

Complete Story »

Test Results Published Show Flash Is Not a ‘CPU Hog’ as Apple Claims

Dan Rayburn submits:
There’s been a lot of discussion on the blogsphere over the last few weeks due to Steve Jobs being quoted as saying one of the reasons Apple (AAPL) won’t support Flash video on the upcoming iPad was due to Flash being a "CPU Hog". Apple’s workaround to Flash video is to use HTML5 [...]

8 Companies That Will Benefit From Cisco’s ‘Internet 2.0′ Initiative

James Altucher submits:
I went on Kudlow’s show on CNBC last night to discuss the new Cisco (CSCO) announcement that, as CSCO put it, “will change the Internet forever.” I mentioned that this was a classic “sell the news” reaction with CSCO stock falling off into the close. Although I didn’t note, CSCO stock had had [...]

Abbott’s Acquisition Spree

Zacks.com submits:
Abbott (ABT) continues to be in an acquisition mode, recently announcing its intention to acquire Facet Biotech Corporation (FACT) for $27 per share. The total purchase price is approximately $722 million, including Facet’s projected cash and marketable securities of approximately $272 million.
Last year, Facet rejected an offer from [...]